|
weekly market: Markets this Week: Sensex, Nifty up over 3%
|
Saturday, February 20, 2016 |
| Market Commentary | | Markets this Week: Sensex, Nifty up over 3% | The Indian markets registered decent gains after three losing Weeks on improved sentiments in global markets. The Sensex and Nifty rose 3.15%-3.29% each for the week ended February 19, 2016. |
Major Headlines for the week: Indian indices: Welcome to the 'Weekly Market Wrap' for Friday, February 19, 2016 where Indian equity markets bounced back in the week ended Friday, 19 February 2016, on positive global cues. The barometer index, the S&P BSE Sensex, regained the psychologically important 23,000 level and the 50-unit Nifty 50 index settled above the psychologically important 7,000 level. The Sensex and the Nifty rose in four out of five trading sessions in the week ended Friday, 19 February 2016.
The broad market depicted strength. The BSE Mid-Cap index rose 1.95%. The BSE Small-Cap index rose 2%. Both these indices underperformed the Sensex. Among the 30 Sensex shares, 26 rose and the remaining shares fell. The Sensex rose 723.03 points or 3.15% to settle at 23,709.15. The Nifty rose 229.80 points or 3.29% to settle at 7,210.75. Weekly market trend from February 15 - February 19, 2016 Feb 15- Trading for the week began on a bullish note. Metal, banking and auto sector stocks led rally on the domestic bourses triggered by firmness in global stocks on Monday. The barometer index, the S&P BSE Sensex, jumped 568 points or 2.47% to settle at 23,554.12. The gains for the 50-unit Nifty 50 index were higher in percentage terms than those for the Sensex. The Nifty rose 182 points or 2.61% to settle at 7,162.95. Feb 16- Stocks of public sector banks and index heavyweights Reliance Industries (RIL) and ITC led losses for key benchmark indices on Tuesday. The barometer index, the S&P BSE Sensex, fell 362.15 points or 1.54% to settle at 23,191.97. The losses for the 50-unit Nifty 50 index were higher in percentage terms than those for the Sensex. The Nifty fell 114.70 points or 1.60% to settle at 7,048.25. The two key benchmark indices extended losses in late trade as European stocks reversed intraday gains. Feb 17- Stocks of public sector banks, pharmaceutical companies and index heavyweights Reliance Industries, Infosys and ITC led upmove for key benchmark indices in what was a volatile trading session on Wednesday. The barometer index, the S&P BSE Sensex, rose 189.90 points or 0.82% to settle at 23,381.87. The 50-unit Nifty 50 index rose 60.20 points or 0.85% to settle at 7,108.45. Gains in European stocks aided the upmove for the two key benchmark indices. Feb 18- Stocks from IT, pharmaceutical sectors and oil exploration and production firms led the upmove for the two key benchmark indices on Thursday , amid signs of stability in global financial markets. The barometer index, the S&P BSE Sensex, rose 267.35 points or 1.14% to settle at 23,649.22. The 50-unit Nifty 50 index rose 83.30 points or 1.17% to settle at 7,191.75. Feb 19- A divergent trend among various index constituents resulted in small gains for key benchmark indices on Friday. The barometer index, the S&P BSE Sensex, rose 59.93 points or 0.25% to settle at 23,709.15. The 50-unit Nifty 50 index rose 19 points or 0.26% to settle at 7,210.75. The Sensex and the Nifty, both, hit their highest closing level in more than a week. Global indices: All the global markets ended in the green zone where Nikkei surged 6.79%, CAC40 jumped 5.71%, Hang Seng surged 5.27% and DAX100 rose 4.69%. 
Sectoral and stock screening: All the sectors ended in the green zone except S&P BSE CD which fell 1.59% while S&P BSE Metal rose 8.52%, S&P BSE CG was up 5.95% and S&P BSE Auto rose 4.91% | Looking at the 'A' group stocks, the top three gainers of the week were: Just Dial up 27.49%, Bank of Baroda rose 22.08% and VEDL up 17.93% Top three losers of the week were: GDL down 13.84%, PI industries fell 13.09% and CARE Ratings was down 8.94% FII/MF activity: The foreign institutional investors (FIIs) have been the net sellers of the Indian stocks to the tune of Rs2205.45 crore as on February 17, 2016 and the domestic investors bought Indian shares worth a net of Rs1057.60 crore as on February 16, 2016. | TOP MOVERS (GROUP A) |  | | | | | | Bank of Baroda | 139.6 | 22.08 | | | | | PI industries | 556.55 | 13.09 | | | | | | | FII/MF ACTIVITIES |  | | | | Gross purchase | 9,735.05 | 2,531.2 | | Gross sale | 1,1940.5 | 1,473.6 | | Net investment | -2,205.45 | 1,057.60 | | | | | | | | *As on February 17, 2016 **As on February 16, 2016 | | | Market Outlook for the coming week! In the coming week, Indian stocks may remain volatile next week as traders roll over positions in the futures & options (F&O) segment from the near month February 2016 series to March 2016 series. The February 2016 derivatives contracts are set to expire on Thursday, 25 February 2016. The two key events lined up during the week are Railway Budget for 2016-17 on Thursday, 25 February 2016, and Economic Survey for 2015-16 on Friday, 26 February 2016. Stocks of companies from steel, cement, coal, iron ore and fertilizer sector will be in focus as Railway Minister Suresh Prabhu presents Railway Budget for 2016-17 in the Lok Sabha on 25 February 2016. Substantial movement for these commodities takes places through the Railways and it remains to be seen if the Rail Minister announces changes in freight rates in the Rail Budget. According to reports, the Railway Minister will unveil a plan in the Rail Budget to cut expenses of the Railways and at the same time increase non-tariff revenue substantially. The Finance Ministry will present Economic Survey for 2015-16 in parliament on 26 February 2016. The annual document reviews the developments in the Indian economy over the previous 12 months, summarizes the performance on major development programmes, highlights the policy initiatives of the government and the prospects of the economy in the short to medium term. Among key global data, Eurozone Markit PMI Composite index for February 2016 is scheduled for release on Monday, 22 February 2016. US new home sales data for the January 2016 is due for release on Tuesday, 23 February 2016. US Q4 GDP data is due on Friday, 26 February 2016. | | To know more about our products and services, click here. | | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/INF231073330 ; CD-INE231073330 ; MCX Stock Exchange - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report. The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com Contact: myaccount@sharekhan.com | | | |
posted by Anonymous @ 5:02 AM  |
|
|
|
|